Elad Mark
Vermogen: 13 252 $ op 31-07-2026
Vermogen: 13 252 $ op 31-07-2026
Elad Mark is currently the Chief Operating Officer at Scinai Immunotherapeutics Ltd. He previously worked at Biopharmax Ltd. as the Head of the Engineering Department from 2006 to 2015.
Mr. Mark holds an MBA from The Open University of Israel, which was conferred in 2013.
He also completed his undergraduate degree at Afeka College of Engineering in 2006.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 19.488.000 ( 0,1% ) | 13 252 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Operationeel Directeur | 01-09-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
Biopharmax Ltd. | Hoofd Techniek/Wetenschap/O&O | 01-06-2015 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
The Open University of Israel
The Open University of Israel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
Biopharmax Ltd. | |
Afeka College of Engineering
Afeka College of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau